2011
DOI: 10.1016/j.jpedsurg.2011.06.002
|View full text |Cite
|
Sign up to set email alerts
|

A contemporary analysis of parenteral nutrition–associated liver disease in surgical infants

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
31
4
1

Year Published

2013
2013
2020
2020

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 39 publications
(36 citation statements)
references
References 24 publications
0
31
4
1
Order By: Relevance
“…By contemporary analyses, approximately 25% of neonates with gastrointestinal disorders will develop PNALD. 37 The incidence and likelihood of developing PNALD vary by specific gastrointestinal diagnosis and report. 1,37,38 Moreover, PNALD incidence increases significantly when a congenital gastrointestinal diagnosis is complicated by any stage of necrotizing enterocolitis.…”
Section: Parenteral Nutrition-associated Liver Diseasementioning
confidence: 99%
See 2 more Smart Citations
“…By contemporary analyses, approximately 25% of neonates with gastrointestinal disorders will develop PNALD. 37 The incidence and likelihood of developing PNALD vary by specific gastrointestinal diagnosis and report. 1,37,38 Moreover, PNALD incidence increases significantly when a congenital gastrointestinal diagnosis is complicated by any stage of necrotizing enterocolitis.…”
Section: Parenteral Nutrition-associated Liver Diseasementioning
confidence: 99%
“…37 The incidence and likelihood of developing PNALD vary by specific gastrointestinal diagnosis and report. 1,37,38 Moreover, PNALD incidence increases significantly when a congenital gastrointestinal diagnosis is complicated by any stage of necrotizing enterocolitis. 1,3741 For children who develop short bowel syndrome (SBS), 67% will develop PNALD and 17% will progress to end-stage liver failure.…”
Section: Parenteral Nutrition-associated Liver Diseasementioning
confidence: 99%
See 1 more Smart Citation
“…In another study of premature neonates (median gestational age of 26 weeks), the frequency of PNALD was considerably higher and ranged from 56 to 85 % [ 8 ]. In a retrospective review of 176 premature infants who received PN, cholestasis occurred in 24 % of infants especially in those with lower gestational age (34 vs. 36 weeks; p < 0.01) and those who received longer duration of PN (76 vs. 21 days; p < 0.001) [ 9 ].…”
Section: Epidemiologymentioning
confidence: 99%
“…Its time to onset is diffi cult to accurately predict due to its association with different risk factors. In a retrospective study of premature infants who received PN, the median time to development of cholestasis was 23 days, with 77 % of infants developing cholestasis within 5 weeks of PN initiation [ 9 ]. Biochemical markers of PNAC typically include elevations of serum bilirubin and γ-glutamyl transpeptidase (GGT) concentrations.…”
Section: Cholestasismentioning
confidence: 99%